Loading…

Characterization of a binding site of 「3 H」semotiadil fumarate, a novel benzothiazine Ca2+ antagonis, in rabbit skeletal muscle membranes

The present study was undertaken to investigate the binding properties of 「^^3 H」semotiadil in rabbit skeletal muscle membranes. 「^^3 H」Semotiadil had a single class of high affinity binding site (Kd=21.6nM. Bmax=6.26 pmol/mg protein, N_H =0.94) in rabbit skeletal muscle membranes. The association a...

Full description

Saved in:
Bibliographic Details
Published in:Japanese Journal of Pharmacology 1995, Vol.67 (suppl.1), p.96-96
Main Authors: Daisuke Shii, Nobuaki Miyawaki, Katsuhiko Nakata, Koichi Nakayama
Format: Article
Language:Japanese
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 96
container_issue suppl.1
container_start_page 96
container_title Japanese Journal of Pharmacology
container_volume 67
creator Daisuke Shii
Nobuaki Miyawaki
Katsuhiko Nakata
Koichi Nakayama
description The present study was undertaken to investigate the binding properties of 「^^3 H」semotiadil in rabbit skeletal muscle membranes. 「^^3 H」Semotiadil had a single class of high affinity binding site (Kd=21.6nM. Bmax=6.26 pmol/mg protein, N_H =0.94) in rabbit skeletal muscle membranes. The association and dissociation of the specific binding of 「^^3 H」semotiadil to the Ca^2+ channel were very rapid. The bind ing was inhibited by SD-3212, S-enantiomer of semotiadil, with a higher Ki(Ki=298.0nM) than semotiadil(Ki=38.6nM), and the speciflc 「^^3 H」semotiadil binding increased under low temperature condition. The specific binding of 「^^3 H」semotiadil was completely inhibited by diltiazem(Ki=368.5nM) and verapamil (Ki=150.7nM). Nifedipine showed a tendency to increase the binding of 「^^3 H」semotiadil. The specific binding of 「^^3 H」semotiadil was hardly affected by CaCl_2 up to 10mM. It has been already reported that unlabeled semotiadil allosterically interacts with the binding sites of (+)-「^^3 H」PN200-110, d-cis-「^^3 H」diltiazem and (-)-「^^3 H」desmethoxyverapamil. Taken together, it is suggested that a high affinity binding site of semotiadil exists on L-type Ca^2+ channels in rabbit skeletal muscle membranes, which may be different from the three well-characterized binding sites of 1,4-dihydropyridines, benzothiazepines and phenylalkylamines.
format article
fullrecord <record><control><sourceid>medicalonline</sourceid><recordid>TN_cdi_medicalonline_journals_cf6jjopl_1995_0067s1_345_0096_0096178215</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>cf6jjopl_1995_0067s1_345_0096_0096178215</sourcerecordid><originalsourceid>FETCH-medicalonline_journals_cf6jjopl_1995_0067s1_345_0096_00961782153</originalsourceid><addsrcrecordid>eNqtTEtOwzAQzQIkKugdZk8r2UnzW0dUPQD7aJxM2gn2GMUOi656AHrKXoQUcQQ27z2930OyUirV21zX1VOyDoGNSlWZVVlar5Jrc8IJu0gTnzGyF_ADIBiWnuUIgSPdndvlO4PD7XIN5Hxk7NnCMLtlGmmz9MV_kQVDcvbxxHhmIWgwfQWUiEcvHDbAAhMawxHCB1mKaMHNobMEjpyZUCi8JI8D2kDrP35O9vu39-awddRzh9aLXZ7b0c-TLHnbDcU4-k_b6rrOW6WKMug2291lXfyCLqtU59m_Hf0A3c1sGQ</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Characterization of a binding site of 「3 H」semotiadil fumarate, a novel benzothiazine Ca2+ antagonis, in rabbit skeletal muscle membranes</title><source>ScienceDirect Journals</source><creator>Daisuke Shii ; Nobuaki Miyawaki ; Katsuhiko Nakata ; Koichi Nakayama</creator><creatorcontrib>Daisuke Shii ; Nobuaki Miyawaki ; Katsuhiko Nakata ; Koichi Nakayama ; School of Pharmaceutical Sciences ; Department of Pharmacology ; Ltd ; University of Shizuoka ; Developmental Research Laboratories ; Santen Pharmaceutical Co</creatorcontrib><description>The present study was undertaken to investigate the binding properties of 「^^3 H」semotiadil in rabbit skeletal muscle membranes. 「^^3 H」Semotiadil had a single class of high affinity binding site (Kd=21.6nM. Bmax=6.26 pmol/mg protein, N_H =0.94) in rabbit skeletal muscle membranes. The association and dissociation of the specific binding of 「^^3 H」semotiadil to the Ca^2+ channel were very rapid. The bind ing was inhibited by SD-3212, S-enantiomer of semotiadil, with a higher Ki(Ki=298.0nM) than semotiadil(Ki=38.6nM), and the speciflc 「^^3 H」semotiadil binding increased under low temperature condition. The specific binding of 「^^3 H」semotiadil was completely inhibited by diltiazem(Ki=368.5nM) and verapamil (Ki=150.7nM). Nifedipine showed a tendency to increase the binding of 「^^3 H」semotiadil. The specific binding of 「^^3 H」semotiadil was hardly affected by CaCl_2 up to 10mM. It has been already reported that unlabeled semotiadil allosterically interacts with the binding sites of (+)-「^^3 H」PN200-110, d-cis-「^^3 H」diltiazem and (-)-「^^3 H」desmethoxyverapamil. Taken together, it is suggested that a high affinity binding site of semotiadil exists on L-type Ca^2+ channels in rabbit skeletal muscle membranes, which may be different from the three well-characterized binding sites of 1,4-dihydropyridines, benzothiazepines and phenylalkylamines.</description><identifier>ISSN: 0021-5198</identifier><language>jpn</language><publisher>The Japanese Pharmacological Society</publisher><ispartof>Japanese Journal of Pharmacology, 1995, Vol.67 (suppl.1), p.96-96</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024</link.rule.ids></links><search><creatorcontrib>Daisuke Shii</creatorcontrib><creatorcontrib>Nobuaki Miyawaki</creatorcontrib><creatorcontrib>Katsuhiko Nakata</creatorcontrib><creatorcontrib>Koichi Nakayama</creatorcontrib><creatorcontrib>School of Pharmaceutical Sciences</creatorcontrib><creatorcontrib>Department of Pharmacology</creatorcontrib><creatorcontrib>Ltd</creatorcontrib><creatorcontrib>University of Shizuoka</creatorcontrib><creatorcontrib>Developmental Research Laboratories</creatorcontrib><creatorcontrib>Santen Pharmaceutical Co</creatorcontrib><title>Characterization of a binding site of 「3 H」semotiadil fumarate, a novel benzothiazine Ca2+ antagonis, in rabbit skeletal muscle membranes</title><title>Japanese Journal of Pharmacology</title><description>The present study was undertaken to investigate the binding properties of 「^^3 H」semotiadil in rabbit skeletal muscle membranes. 「^^3 H」Semotiadil had a single class of high affinity binding site (Kd=21.6nM. Bmax=6.26 pmol/mg protein, N_H =0.94) in rabbit skeletal muscle membranes. The association and dissociation of the specific binding of 「^^3 H」semotiadil to the Ca^2+ channel were very rapid. The bind ing was inhibited by SD-3212, S-enantiomer of semotiadil, with a higher Ki(Ki=298.0nM) than semotiadil(Ki=38.6nM), and the speciflc 「^^3 H」semotiadil binding increased under low temperature condition. The specific binding of 「^^3 H」semotiadil was completely inhibited by diltiazem(Ki=368.5nM) and verapamil (Ki=150.7nM). Nifedipine showed a tendency to increase the binding of 「^^3 H」semotiadil. The specific binding of 「^^3 H」semotiadil was hardly affected by CaCl_2 up to 10mM. It has been already reported that unlabeled semotiadil allosterically interacts with the binding sites of (+)-「^^3 H」PN200-110, d-cis-「^^3 H」diltiazem and (-)-「^^3 H」desmethoxyverapamil. Taken together, it is suggested that a high affinity binding site of semotiadil exists on L-type Ca^2+ channels in rabbit skeletal muscle membranes, which may be different from the three well-characterized binding sites of 1,4-dihydropyridines, benzothiazepines and phenylalkylamines.</description><issn>0021-5198</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqtTEtOwzAQzQIkKugdZk8r2UnzW0dUPQD7aJxM2gn2GMUOi656AHrKXoQUcQQ27z2930OyUirV21zX1VOyDoGNSlWZVVlar5Jrc8IJu0gTnzGyF_ADIBiWnuUIgSPdndvlO4PD7XIN5Hxk7NnCMLtlGmmz9MV_kQVDcvbxxHhmIWgwfQWUiEcvHDbAAhMawxHCB1mKaMHNobMEjpyZUCi8JI8D2kDrP35O9vu39-awddRzh9aLXZ7b0c-TLHnbDcU4-k_b6rrOW6WKMug2291lXfyCLqtU59m_Hf0A3c1sGQ</recordid><startdate>1995</startdate><enddate>1995</enddate><creator>Daisuke Shii</creator><creator>Nobuaki Miyawaki</creator><creator>Katsuhiko Nakata</creator><creator>Koichi Nakayama</creator><general>The Japanese Pharmacological Society</general><scope/></search><sort><creationdate>1995</creationdate><title>Characterization of a binding site of 「3 H」semotiadil fumarate, a novel benzothiazine Ca2+ antagonis, in rabbit skeletal muscle membranes</title><author>Daisuke Shii ; Nobuaki Miyawaki ; Katsuhiko Nakata ; Koichi Nakayama</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-medicalonline_journals_cf6jjopl_1995_0067s1_345_0096_00961782153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>jpn</language><creationdate>1995</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Daisuke Shii</creatorcontrib><creatorcontrib>Nobuaki Miyawaki</creatorcontrib><creatorcontrib>Katsuhiko Nakata</creatorcontrib><creatorcontrib>Koichi Nakayama</creatorcontrib><creatorcontrib>School of Pharmaceutical Sciences</creatorcontrib><creatorcontrib>Department of Pharmacology</creatorcontrib><creatorcontrib>Ltd</creatorcontrib><creatorcontrib>University of Shizuoka</creatorcontrib><creatorcontrib>Developmental Research Laboratories</creatorcontrib><creatorcontrib>Santen Pharmaceutical Co</creatorcontrib><jtitle>Japanese Journal of Pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Daisuke Shii</au><au>Nobuaki Miyawaki</au><au>Katsuhiko Nakata</au><au>Koichi Nakayama</au><aucorp>School of Pharmaceutical Sciences</aucorp><aucorp>Department of Pharmacology</aucorp><aucorp>Ltd</aucorp><aucorp>University of Shizuoka</aucorp><aucorp>Developmental Research Laboratories</aucorp><aucorp>Santen Pharmaceutical Co</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization of a binding site of 「3 H」semotiadil fumarate, a novel benzothiazine Ca2+ antagonis, in rabbit skeletal muscle membranes</atitle><jtitle>Japanese Journal of Pharmacology</jtitle><date>1995</date><risdate>1995</risdate><volume>67</volume><issue>suppl.1</issue><spage>96</spage><epage>96</epage><pages>96-96</pages><issn>0021-5198</issn><abstract>The present study was undertaken to investigate the binding properties of 「^^3 H」semotiadil in rabbit skeletal muscle membranes. 「^^3 H」Semotiadil had a single class of high affinity binding site (Kd=21.6nM. Bmax=6.26 pmol/mg protein, N_H =0.94) in rabbit skeletal muscle membranes. The association and dissociation of the specific binding of 「^^3 H」semotiadil to the Ca^2+ channel were very rapid. The bind ing was inhibited by SD-3212, S-enantiomer of semotiadil, with a higher Ki(Ki=298.0nM) than semotiadil(Ki=38.6nM), and the speciflc 「^^3 H」semotiadil binding increased under low temperature condition. The specific binding of 「^^3 H」semotiadil was completely inhibited by diltiazem(Ki=368.5nM) and verapamil (Ki=150.7nM). Nifedipine showed a tendency to increase the binding of 「^^3 H」semotiadil. The specific binding of 「^^3 H」semotiadil was hardly affected by CaCl_2 up to 10mM. It has been already reported that unlabeled semotiadil allosterically interacts with the binding sites of (+)-「^^3 H」PN200-110, d-cis-「^^3 H」diltiazem and (-)-「^^3 H」desmethoxyverapamil. Taken together, it is suggested that a high affinity binding site of semotiadil exists on L-type Ca^2+ channels in rabbit skeletal muscle membranes, which may be different from the three well-characterized binding sites of 1,4-dihydropyridines, benzothiazepines and phenylalkylamines.</abstract><pub>The Japanese Pharmacological Society</pub></addata></record>
fulltext fulltext
identifier ISSN: 0021-5198
ispartof Japanese Journal of Pharmacology, 1995, Vol.67 (suppl.1), p.96-96
issn 0021-5198
language jpn
recordid cdi_medicalonline_journals_cf6jjopl_1995_0067s1_345_0096_0096178215
source ScienceDirect Journals
title Characterization of a binding site of 「3 H」semotiadil fumarate, a novel benzothiazine Ca2+ antagonis, in rabbit skeletal muscle membranes
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T19%3A12%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-medicalonline&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20of%20a%20binding%20site%20of%20%E3%80%8C3%20H%E3%80%8Dsemotiadil%20fumarate,%20a%20novel%20benzothiazine%20Ca2+%20antagonis,%20in%20rabbit%20skeletal%20muscle%20membranes&rft.jtitle=Japanese%20Journal%20of%20Pharmacology&rft.au=Daisuke%20Shii&rft.aucorp=School%20of%20Pharmaceutical%20Sciences&rft.date=1995&rft.volume=67&rft.issue=suppl.1&rft.spage=96&rft.epage=96&rft.pages=96-96&rft.issn=0021-5198&rft_id=info:doi/&rft_dat=%3Cmedicalonline%3Ecf6jjopl_1995_0067s1_345_0096_0096178215%3C/medicalonline%3E%3Cgrp_id%3Ecdi_FETCH-medicalonline_journals_cf6jjopl_1995_0067s1_345_0096_00961782153%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true